WVP
FEED

Worth Venture Partners’s ENvue Medical Inc FEED Stock Holding History

Worth Venture Partners’s Portfolio FEED Stock Details FEED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-49
Closed -$243K – 130
2020
Q2 		$243K Sell
49
-1
-2% -$4.67K 0.12% 88
2020
Q1 		$236K Buy
50
+42
+525% +$246K 0.15% 70
2019
Q4 		$47K Sell
8
-1
-11% -$6.36K 0.02% 78
2019
Q3 		$50K Hold
9
– – 0.03% 85
2019
Q2 		$58K Hold
9
– – 0.03% 82
2019
Q1 		$82K Hold
9
– – 0.05% 75
2018
Q4 		$72K Hold
9
– – 0.05% 74
2018
Q3 		$92K Buy
+9
New +$90.8K 0.07% 106

Other funds holding FEED

KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
AFS
Amtrust Financial Services New York $300M AUM 12.98% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Worth Venture Partners's FEED Position: Q3 2020 in Review

Worth Venture Partners sold out of ENvue Medical Inc (FEED) in Q3 2020, closing a stake of 49 shares — an estimated $243K sold.

Worth Venture Partners first reported a position in FEED in Q3 2018 and held it in 8 quarters. The position peaked at $243K in Q2 2020. 6 funds tracked by Wall St. Rank hold FEED as of Q3 2020.

  • Worth Venture Partners reported no remaining ENvue Medical Inc position as of Q3 2020 after selling out during the quarter.
  • Worth Venture Partners sold 49 ENvue Medical Inc shares in Q3 2020, an estimated $243K.
  • Worth Venture Partners first reported a position in ENvue Medical Inc in Q3 2018 and held it in 8 quarters.
  • Worth Venture Partners's ENvue Medical Inc position peaked at $243K in Q2 2020.
  • 6 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q3 2020.

Based on Worth Venture Partners's 13F filing for Q3 2020, filed 16 Nov 2020.